Terms: = Breast cancer AND PAX7, PAX7B, 5081, ENSG00000009709, P23759, HUP1 AND Treatment
5 results:
1. Analysis of breast cancer Family History, Estrogen Receptor Status, and breast cancer Outcomes in Sweden.
Zhang Y; Wang QL; Zeng E; He W; Czene K
JAMA Netw Open; 2023 Jun; 6(6):e2318053. PubMed ID: 37310740
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in breast cancer: A Systematic Review and Meta-Analysis.
Jayaraj R; Nayagam SG; Kar A; Sathyakumar S; Mohammed H; Smiti M; Sabarimurugan S; Kumarasamy C; Priyadharshini T; Gothandam KM; Ramesh N; Gupta A; Baxi S; Swamiappan S; Krishnan S
Cells; 2019 Oct; 8(10):. PubMed ID: 31615089
[TBL] [Abstract] [Full Text] [Related]
3. Pharmacological Dual Inhibition of Tumor and Tumor-Induced Functional Limitations in a Transgenic Model of breast cancer.
Wang R; Bhat-Nakshatri P; Padua MB; Prasad MS; Anjanappa M; Jacobson M; Finnearty C; Sefcsik V; McElyea K; Redmond R; Sandusky G; Penthala N; Crooks PA; Liu J; Zimmers T; Nakshatri H
Mol Cancer Ther; 2017 Dec; 16(12):2747-2758. PubMed ID: 28978719
[TBL] [Abstract] [Full Text] [Related]
4. Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer: impact on overall survival.
Dragun AE; Huang B; Tucker TC; Spanos WJ
Cancer; 2011 Jun; 117(12):2590-8. PubMed ID: 21656737
[TBL] [Abstract] [Full Text] [Related]
5. Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma.
Oesch S; Walter D; Wachtel M; Pretre K; Salazar M; Guzmán M; Velasco G; Schäfer BW
Mol Cancer Ther; 2009 Jul; 8(7):1838-45. PubMed ID: 19509271
[TBL] [Abstract] [Full Text] [Related]
